Patel, Akash
Buszkiewicz, James H.
Cook, Steven
Arenberg, Douglas A.
Fleischer, Nancy L.
Funding for this research was provided by:
National Cancer Institute of the National Institutes of Health (NIH) and the Food and Drug Administration’s (FDA) Center for Tobacco Products (U54CA229974, U54CA229974, U54CA229974, U54CA229974, U54CA229974)
Article History
Received: 29 February 2024
Accepted: 31 July 2024
First Online: 10 August 2024
Declarations
:
: The PATH Study was conducted by Westat and approved by the Westat Institutional Review Board. All adult respondents (age 18+) in the PATH Study provided informed consent. This study was considered not regulated by the University of Michigan Institutional Review Board since only secondary, de-identified data was utilized.
: Not applicable.
: The authors declare no competing interests.
: The opinions expressed in this work are the authors’ own and do not reflect the views of the National Institutes of Health, the Food and Drug Administration, the Department of Health and Human Services, nor the United States government.